A Single-center, Active-controlled, Randomized, Double-blind, Proof of Concept Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application in Male Patients With Androgenetic Alopecia

Trial Profile

A Single-center, Active-controlled, Randomized, Double-blind, Proof of Concept Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application in Male Patients With Androgenetic Alopecia

Completed
Phase of Trial: Phase I/II

Latest Information Update: 26 Jun 2015

At a glance

  • Drugs Finasteride (Primary) ; Minoxidil
  • Indications Alopecia
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Dong-A ST
  • Most Recent Events

    • 26 Jun 2015 Last checked against ClinicalTrials.gov record.
    • 23 Jun 2015 Status changed from active, no longer recruiting to completed ClinicalTrials.gov record.
    • 01 Dec 2014 Planned End Date changed from 1 Oct 2014 to 1 Jan 2015 ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top